Collectively, these observations suggest that the rapa-treated mice were producing, storing, and releasing less insulin, likely explaining the increased hyperglycemia, while the untreated mice showed a pattern consistent with developing insulin resistance. This evidence concerns the gene TRERF1 and Hyperglycemia.